Cereno Scientific publishes the interim report for Q1 2023 ( January 1 – March 31)
The Board and Chief Executive Officer of Cereno Scientific AB here present the interim report for Q1 2023 ( January 1 – March 31).Summary of the interim report for Q1 2023 ( January 1 – March 31) Cereno Scientific Group · Net Sales were SEK 0 (0) · Result after financial items was SEK 4,409,588 (-5,246,969) · Earnings per share was SEK -0.03 (-0.05) before dilution and SEK -0.03 (-0.04) after dilution · The equity/assets ratio was 94.3% (93.4%) · Cash and bank balance was SEK 44,622,145 SEK (77,268,668) Parent company · Net Sales were SEK 0 (0) · Result after